Table 4. Occurrence of individual adverse events.
Adverse events (n) | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
---|---|---|---|---|
Alopecia | 16 (34.0%) | 12 (25.5%) | 19 (40.4%) | 0 (0%) |
Nail ridging | 42 (89.4%) | 5 (10.5%) | 0 (0%) | 0 0%) |
Dry skin | 40 (85.1%) | 7 (14.9%) | 0 (0%) | 0 (0%) |
Nausea | 35 (74.5%) | 9 (19.1%) | 3 (6.4%) | 0 (0%) |
Constipation | 31 (66.0%) | 12 (25.5%) | 3 (6.4%) | 1 (2.1%) |
Mucositis oral | 35 (74.5%) | 10 (21.3%) | 2 (4.3%) | 0 (0%) |
Oral pain | 42 (89.4%) | 5 (10.6%) | 0 (0%) | 0 0%) |
Peripheral sensory neuropathy | 38 (80.9%) | 9 (19.1%) | 0 (0%) | 0 (0%) |
Dysgeusia | 39 (83.0%) | 3 (6.4%) | 5 (10.6%) | 0 (0%) |
Malaise | 21 (44.7%) | 19 (40.4%) | 7 (14.9%) | 0 0%) |
Fever | 40 (85.1%) | 7 (14.9%) | 0 (0%) | 0 (0%) |
White blood cell decreased | 37 (78.7%) | 8 (17.0%) | 2 (4.3%) | 0 (0%) |
Anemia | 29 (61.7%) | 18 (38.3%) | 0 (0%) | 0 0%) |
Anorexia | 27 (57.4%) | 9 (19.1%) | 11 (23.4%) | 0 (0%) |